202, 1201-5th Street SW
Calgary, AB T2R 0Y6
Canada
403 910 5140
https://www.willowbio.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 19
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. Chris Savile | President, Director & CEO | 359.85k | N/A | N/A |
Mr. Travis Doupe | Chief Financial Officer | 276.53k | N/A | 1972 |
Dr. Trish Choudhary | Senior Vice President of Research & Development | 246.81k | N/A | N/A |
Mr. Troy T. Talkkari | Vice President of Corporate Development | 153.58k | N/A | N/A |
Mr. Sanjib Singh Gill L.L.B. | Corporate Secretary | N/A | N/A | 1976 |
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
Willow Biosciences Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.